Network-based Cancer Precision Prevention with Artificial Intelligence and Multi-Omics.

Peng Zhang,Boyang Wang,Shao Li

DOI: https://doi.org/10.1016/j.scib.2023.05.023

IF: 18.9

2023-01-01

Science Bulletin

Abstract:Cancer is recognized as a leading cause of deaths nowadays,accounting for 10 million annual deaths worldwide and resulting in heavy health and economic burdens[1].Reducing cancer inci-dence through precision prevention is thus of great scientific and clinical value.Gastric cancer(GC)is one of the most common can-cers in China.Pathologically,the onset of GC,especially the intesti-nal-type ones,would usually suffer a series of premalignant lesions,including atrophic gastritis,intestinal metaplasia,and low-grade dysplasia(LGD),which is known as the process of gas-tritis-induced tumorigenesis(GIGT)[2].Epidemiological studies have shown that GIGT has exhibited the characteristics of long-term and low-probability,that is,only a small number of gastritis patients would develop into GC after a long period.Therefore,it has become the key challenge for GC precision prevention that how to uncover the biological mechanism underlying GIGT,fol-lowed by accurately identifying the critical time point at which effective diagnosis and treatment strategies could be developed to prevent GC.Of note,this is also a common challenge for the pre-cision prevention of other cancer types,such as liver and colon cancers.